Inventia Life Sciences specializes in developing cutting-edge solutions for creating advanced 3D cell models, which are crucial for accelerating biomedical research and drug discovery. The company serves a diverse range of clients, including researchers, pharmaceutical companies, and academic institutions, who are at the forefront of medical and scientific innovation. Operating in the biotechnology and life sciences market, Inventia leverages its proprietary technology to offer ready-to-use, xeno-free matrices that support various cell and tissue types. Their instruments feature an intuitive user experience with integrated dual HEPA filtration, making them accessible to users without coding expertise. The business model revolves around selling these advanced tools and consumables, generating revenue through direct sales and long-term partnerships with research institutions and pharmaceutical companies. Inventia's technology is also transforming skin regeneration, driving a paradigm shift in personalized clinical therapies for skin trauma. By integrating seamlessly with standard well plates and downstream analysis, their models facilitate high-quality in situ imaging and comprehensive data collection.

Keywords: 3D cell models, biomedical research, drug discovery, xeno-free matrices, intuitive instruments, dual HEPA filtration, skin regeneration, personalized therapies, neurodegenerative diseases, iPSCs.